Herpes zoster and postherpetic neuralgia surveillance using structured electronic data

Mayo Clinic Proceedings

Volumn 86, Issue 12, 2011, Pages 1146-1153

  Klompas, Michael ^a   Kulldorff, Martin ^a   Vilk, Yury ^a   Bialek, Stephanie R ^b   Harpaz, Rafael ^b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT;

ADULT; AGED; ALGORITHM; ARTICLE; AUTOMATION; DISEASE SURVEILLANCE; ELECTRONIC ALGORITHM; ELECTRONIC MEDICAL RECORD; FEMALE; HERPES ZOSTER; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; POSTHERPETIC NEURALGIA; PREDICTIVE VALUE; PRESCRIPTION; SENSITIVITY ANALYSIS;

EID: 83155193096     PISSN: 00256196     EISSN: None     Source Type: Journal    
DOI: 10.4065/mcp.2011.0305     Document Type: Article

References (30)

1. Insinga RP, Itzler RF, Pellissier JM, Saddier P, Nikas AA. The incidence of herpes zoster in a United States administrative database. J Gen Intern Med. 2005;20:748-753. (Pubitemid 41141008)
2. Choo PW, Donahue JG, Manson JE, Platt R. The epidemiology of varicella and its complications. J Infect Dis. 1995;172:706-712.
3. Vázquez M, Shapiro ED. Varicella vaccine and infection with varicellazoster virus. N Engl J Med. 2005;352(5):439-440. (Pubitemid 40175969)
4. Yawn BP, Saddier P, Wollan PC, St Sauver JL, Kurland MJ, Sy LS. A population-based study of the incidence and complication rates of herpes zoster before zoster vaccine introduction. Mayo Clin Proc. 2007;82:1341-1349. (Pubitemid 350060129)
5. Opstelten W, Mauritz JW, de Wit NJ, van Wijck AJ, Stalman WA, van Essen GA. Herpes zoster and postherpetic neuralgia: incidence and risk indicators using a general practice research database. Fam Pract. 2002;19:471-475. (Pubitemid 35244231)
6. Choo PW, Galil K, Donahue JG, Walker AM, Spiegelman D, Platt R. Risk factors for postherpetic neuralgia. Arch Intern Med. 1997;157:1217-1224. (Pubitemid 27251649)
7. Ragozzino MW, Melton LJ III, Kurland LT, Chu CP, Perry HO. Population- based study of herpes zoster and its sequelae. Medicine (Baltimore). 1982;61:310-316. (Pubitemid 12031812)
8. Oxman MN, Levin MJ, Johnson GR, et al. A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N Engl J Med. 2005;352: 2271-2284.
9. Schmader KE, Sloane R, Pieper C, et al. The impact of acute herpes zoster pain and discomfort on functional status and quality of life in older adults. Clin J Pain. 2007;23:490-496. (Pubitemid 46956185)
10. Coplan PM, Schmader K, Nikas A, et al. Development of a measure of the burden of pain due to herpes zoster and postherpetic neuralgia for prevention trials: adaptation of the brief pain inventory. J Pain. 2004;5:344-356. (Pubitemid 39164674)
11. Katz J, Cooper EM, Walther RR, Sweeney EW, Dworkin RH. Acute pain in herpes zoster and its impact on health-related quality of life. Clin Infect Dis. 2004;39:342-348. (Pubitemid 39050481)
12. Reynolds MA, Chaves SS, Harpaz R, Lopez AS, Seward JF. The impact of the varicella vaccination program on herpes zoster epidemiology in the United States: a review. J Infect Dis. 2008;197(suppl 2):S224-S227. (Pubitemid 351590175)
13. Harpaz R, Yawn BP. Trends in rates of herpes zoster-related hospitalizations: are they real, are they costly, and are they linked to varicella vaccination [letter]? Infect Control Hosp Epidemiol. 2009;30(5):495-496.
14. Thomas SL, Wheeler JG, Hall AJ. Contacts with varicella or with children and protection against herpes zoster in adults: a case-control study. Lancet. 2002;360:678-682. (Pubitemid 35232336)
15. Thomas SL, Hall AJ. What does epidemiology tell us about risk factors for herpes zoster? Lancet Infect Dis. 2004;4:26-33. (Pubitemid 38057055)
16. Brisson M, Pellissier JM, Levin MJ. Cost-effectiveness of herpes zoster vaccine: flawed assumptions regarding efficacy against postherpetic neuralgia. Clin Infect Dis. 2007;45:1527-1529. (Pubitemid 351411890)
17. Oxman MN, Levin MJ. Vaccination against herpes zoster and postherpetic neuralgia. J Infect Dis. 2008;197(suppl 2):S228-S236. (Pubitemid 351590176)
18. Tseng HF, Smith N, Harpaz R, Bialek SR, Sy LS, Jacobsen SJ. Herpes zoster vaccine in older adults and the risk of subsequent herpes zoster disease. JAMA. 2011;305(2):160-166.
19. Leung J, Harpaz R, Molinari NA, Jumaan A, Zhou F. Herpes zoster incidence among insured persons in the United States, 1993-2006: evaluation of impact of varicella vaccination. Clin Infect Dis. 2011;52:332-340.
20. Jumaan AO, Yu O, Jackson LA, Bohlke K, Galil K, Seward JF. Incidence of herpes zoster, before and after varicella-vaccination-associated decreases in the incidence of varicella, 1992-2002. J Infect Dis. 2005;191:2002-2007. (Pubitemid 40800569)
21. Mullooly JP, Riedlinger K, Chun C, Weinmann S, Houston H. Incidence of herpes zoster, 1997-2002. Epidemiol Infect. 2005;133:245-253. (Pubitemid 40439304)
22. Pellissier JM, Brisson M, Levin MJ. Evaluation of the cost-effectiveness in the United States of a vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. Vaccine. 2007;25:8326-8337. (Pubitemid 350087379)
23. Rothberg MB, Virapongse A, Smith KJ. Cost-effectiveness of a vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. Clin Infect Dis. 2007;44:1280-1288. (Pubitemid 46717289)
24. Scott FT, Johnson RW, Leedham-Green M, Davies E, Edmunds WJ, Breuer J. The burden of herpes zoster: a prospective population based study. Vaccine. 2006;24:1308-1314. (Pubitemid 43222038)
25. Jung BF, Johnson RW, Griffin DR, Dworkin RH. Risk factors for postherpetic neuralgia in patients with herpes zoster. Neurology. 2004;62:1545-1551. (Pubitemid 38608193)
26. Harpaz R, Ortega-Sanchez IR, Seward JF. Prevention of herpes zoster: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2008;57(RR-5):1-30.
27. Lu PJ, Euler GL, Jumaan AO, Harpaz R. Herpes zoster vaccination among adults aged 60 years or older in the United States, 2007: uptake of the first new vaccine to target seniors. Vaccine. 2009;27:882-887.
28. Smith PC, Araya-Guerra R, Bublitz C, et al. Missing clinical information during primary care visits. JAMA. 2005;293(5):565-571.
29. Lazarus R, Klompas M, Campion FX, et al. Electronic support for public health: validated case finding and reporting for notifiable diseases using electronic medical data. J Am Med Inform Assoc. 2009;16:18-24.
30. Centers for Disease Control and Prevention (CDC). Automated detection and reporting of notifiable diseases using electronic medical records versus passive surveillance-Massachusetts, June 2006-July 2007. MMWR Morb Mortal Wkly Rep. 2008;57:373-376.